Oxytetracycline‐induced thrombocytopenic purpura

1 amyloidosis. Another case of amyloidosis complicating nonsecretory MM was described by Azaret al. [3]. It is interesting to speculate on the origin of the aniyloid fibrils in the absence of an overt monoclonal protein. Four of the 14 patients with nonsecretory MM reported by Preud’homme et al. [2] had Bence Jones proteins in their serum or urine at some stage of their disease. Three of the five nonexcretory myeloid patients described by Joyner et al. [4] had some monoclonal protein excretion, either at the initial or the terminal stages of their disease. Initial excretion could be the result of a very low cellular excretory rate. enabling detection of the paraprotein only when the tumor mass is maximal. Terminal excretion of monoclonal protein could also be related to alteration in tumor mass. Thus nonsecretory cells may in reality be capable of excreting secreted immunoglobulin, as suggested by the presence of surface monoclonal immunoglobulin in most cases of nonsecretory myeloma patients [2,4.5]. Preud’homme et al. [2] suggested that the inability to detect serum or urinaq immunoglobulin may be due to a chain defect that confers a susceptibility to rapid extracellular enzymatic breakdown of the immunoglobulin. The occurrence of amyloid deposits in some rare cases of nonsecretory MM, including ours, favors such a hypothesis.

[1]  A. Marcelli-Barge Thrombopénies et leucopénies immuno-allergiques d'origine médicamenteuse. , 1989 .

[2]  V. Kiefel,et al.  Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. , 1987, Blood.

[3]  F. Oosterhof,et al.  A Simple Immunofluorescence Test for the Detection of Platelet Antibodies , 1978, British journal of haematology.

[4]  J. Brouet,et al.  Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. , 1976, Clinical and experimental immunology.

[5]  C. W. Parker,et al.  Drug allergy (first of three parts). , 1975, The New England journal of medicine.

[6]  N. Kounis Oxytetracycline-induced thrombocytopenic purpura. , 1975, JAMA.

[7]  Rodney Harris,et al.  HL-A AND RENAL GRAFT SURVIVAL , 1974 .

[8]  H. A. Azar,et al.  "Nonsecretory" plasma cell myeloma: observations on seven cases with electron microscopic studies. , 1972, American journal of clinical pathology.

[9]  A G BECKETT,et al.  Thrombocytopenic purpura associated with oxytetracycline therapy. , 1955, Lancet.

[10]  Ackroyd Jf The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid. , 1949 .

[11]  A. Salama,et al.  Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. , 1990, Transfusion medicine reviews.

[12]  J. Ackroyd The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid. , 1949, Clinical science.